Amyloid β (Aβ) inhibits retinal angiogenesis in Alzheimer's disease via LncRNA-XIST/miRNA-126-5p/VEGF axis

Alzheimer's disease (AD) is often accompanied by retinal lesions, in which Amyloid β (Aβ) is a key mediator. Vascular dysfunction is always associated with the malignant progression of AD, but the precise mechanisms remain poorly understood. The aim of this study is to investigate how Aβ regula...

Full description

Saved in:
Bibliographic Details
Main Authors: Bin Wang, Wenwei Li, Chaoyang Hong, Fangfang Jin, Baisheng Xu, Zhongwei Guo, Shuyang Chen, Qi Zhang
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Immunobiology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0171298525002311
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839623788650561536
author Bin Wang
Wenwei Li
Chaoyang Hong
Fangfang Jin
Baisheng Xu
Zhongwei Guo
Shuyang Chen
Qi Zhang
author_facet Bin Wang
Wenwei Li
Chaoyang Hong
Fangfang Jin
Baisheng Xu
Zhongwei Guo
Shuyang Chen
Qi Zhang
author_sort Bin Wang
collection DOAJ
description Alzheimer's disease (AD) is often accompanied by retinal lesions, in which Amyloid β (Aβ) is a key mediator. Vascular dysfunction is always associated with the malignant progression of AD, but the precise mechanisms remain poorly understood. The aim of this study is to investigate how Aβ regulates retinal angiogenesis in AD models through the LncRNA-XIST/miR-126-5p/VEGF axis. The research results showed that in the retina of AD model mice, the expression of Aβ and miR-126-5p increased, while the expression of LncRNA-XIST and VEGF decreased. In vitro experiments demonstrated that Aβ treatment downregulated LncRNA-XIST and VEGF expression in RF/6 A cells, while upregulating miR-126-5p and significantly suppressing angiogenesis. Overexpression of LncRNA-XIST can reverse the inhibitory effect of Aβ on angiogenesis, while further overexpression of miR-126-5p can counteract the pro-angiogenic effect of LncRNA-XIST. The dual-luciferase reporter assay results showed that Aβ repressed the transcriptional activity of the LncRNA-XIST promoter by targeting the −800 to −600 fragment. Mechanism studies have revealed that LncRNA-XIST competitively binds to miR-126-5p, preventing its binding to VEGF mRNA and upregulating VEGF expression. In vivo experiments demonstrated that miR-126-5p inhibitor resulted in elevated expression of LncRNA-XIST and VEGF in the mouse retina. This study reveals the molecular mechanism by which Aβ regulates retinal angiogenesis in AD models through the LncRNA-XIST/miR-126-5p/VEGF axis, providing a potential new strategy for targeted therapy of AD-related retinal lesions.
format Article
id doaj-art-9c78f00e7a3843d5b6d1a75d00b4753a
institution Matheson Library
issn 0171-2985
language English
publishDate 2025-07-01
publisher Elsevier
record_format Article
series Immunobiology
spelling doaj-art-9c78f00e7a3843d5b6d1a75d00b4753a2025-07-19T04:37:48ZengElsevierImmunobiology0171-29852025-07-012304153097Amyloid β (Aβ) inhibits retinal angiogenesis in Alzheimer's disease via LncRNA-XIST/miRNA-126-5p/VEGF axisBin Wang0Wenwei Li1Chaoyang Hong2Fangfang Jin3Baisheng Xu4Zhongwei Guo5Shuyang Chen6Qi Zhang7The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China; Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang, China; Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, ChinaZhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang, China; Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, China; Corresponding author at: Zhejiang Academy of Traditional Chinese Medicine, No. 234, Gucui Road, Xihu district, Hangzhou, Zhejiang Province, China.Eye Center of Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, ChinaThe Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, ChinaZhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang, China; Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, ChinaZhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang, China; Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, ChinaZhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang, China; Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, ChinaEye Center of the Second Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, ChinaAlzheimer's disease (AD) is often accompanied by retinal lesions, in which Amyloid β (Aβ) is a key mediator. Vascular dysfunction is always associated with the malignant progression of AD, but the precise mechanisms remain poorly understood. The aim of this study is to investigate how Aβ regulates retinal angiogenesis in AD models through the LncRNA-XIST/miR-126-5p/VEGF axis. The research results showed that in the retina of AD model mice, the expression of Aβ and miR-126-5p increased, while the expression of LncRNA-XIST and VEGF decreased. In vitro experiments demonstrated that Aβ treatment downregulated LncRNA-XIST and VEGF expression in RF/6 A cells, while upregulating miR-126-5p and significantly suppressing angiogenesis. Overexpression of LncRNA-XIST can reverse the inhibitory effect of Aβ on angiogenesis, while further overexpression of miR-126-5p can counteract the pro-angiogenic effect of LncRNA-XIST. The dual-luciferase reporter assay results showed that Aβ repressed the transcriptional activity of the LncRNA-XIST promoter by targeting the −800 to −600 fragment. Mechanism studies have revealed that LncRNA-XIST competitively binds to miR-126-5p, preventing its binding to VEGF mRNA and upregulating VEGF expression. In vivo experiments demonstrated that miR-126-5p inhibitor resulted in elevated expression of LncRNA-XIST and VEGF in the mouse retina. This study reveals the molecular mechanism by which Aβ regulates retinal angiogenesis in AD models through the LncRNA-XIST/miR-126-5p/VEGF axis, providing a potential new strategy for targeted therapy of AD-related retinal lesions.http://www.sciencedirect.com/science/article/pii/S0171298525002311Alzheimer's diseaseRetinopathyAmyloid βLncRNA-XISTmiR-126-5pVEGF
spellingShingle Bin Wang
Wenwei Li
Chaoyang Hong
Fangfang Jin
Baisheng Xu
Zhongwei Guo
Shuyang Chen
Qi Zhang
Amyloid β (Aβ) inhibits retinal angiogenesis in Alzheimer's disease via LncRNA-XIST/miRNA-126-5p/VEGF axis
Immunobiology
Alzheimer's disease
Retinopathy
Amyloid β
LncRNA-XIST
miR-126-5p
VEGF
title Amyloid β (Aβ) inhibits retinal angiogenesis in Alzheimer's disease via LncRNA-XIST/miRNA-126-5p/VEGF axis
title_full Amyloid β (Aβ) inhibits retinal angiogenesis in Alzheimer's disease via LncRNA-XIST/miRNA-126-5p/VEGF axis
title_fullStr Amyloid β (Aβ) inhibits retinal angiogenesis in Alzheimer's disease via LncRNA-XIST/miRNA-126-5p/VEGF axis
title_full_unstemmed Amyloid β (Aβ) inhibits retinal angiogenesis in Alzheimer's disease via LncRNA-XIST/miRNA-126-5p/VEGF axis
title_short Amyloid β (Aβ) inhibits retinal angiogenesis in Alzheimer's disease via LncRNA-XIST/miRNA-126-5p/VEGF axis
title_sort amyloid β aβ inhibits retinal angiogenesis in alzheimer s disease via lncrna xist mirna 126 5p vegf axis
topic Alzheimer's disease
Retinopathy
Amyloid β
LncRNA-XIST
miR-126-5p
VEGF
url http://www.sciencedirect.com/science/article/pii/S0171298525002311
work_keys_str_mv AT binwang amyloidbabinhibitsretinalangiogenesisinalzheimersdiseasevialncrnaxistmirna1265pvegfaxis
AT wenweili amyloidbabinhibitsretinalangiogenesisinalzheimersdiseasevialncrnaxistmirna1265pvegfaxis
AT chaoyanghong amyloidbabinhibitsretinalangiogenesisinalzheimersdiseasevialncrnaxistmirna1265pvegfaxis
AT fangfangjin amyloidbabinhibitsretinalangiogenesisinalzheimersdiseasevialncrnaxistmirna1265pvegfaxis
AT baishengxu amyloidbabinhibitsretinalangiogenesisinalzheimersdiseasevialncrnaxistmirna1265pvegfaxis
AT zhongweiguo amyloidbabinhibitsretinalangiogenesisinalzheimersdiseasevialncrnaxistmirna1265pvegfaxis
AT shuyangchen amyloidbabinhibitsretinalangiogenesisinalzheimersdiseasevialncrnaxistmirna1265pvegfaxis
AT qizhang amyloidbabinhibitsretinalangiogenesisinalzheimersdiseasevialncrnaxistmirna1265pvegfaxis